Suppr超能文献

白术内酯Ⅰ通过抑制MAPK/NF-κB信号通路改善对乙酰氨基酚诱导的小鼠急性肝损伤

[Atractylenolide Ⅰ improves acetaminophen-induced acute liver injury in mice by inhibiting MAPK/NF-κB signaling pathway].

作者信息

Ma Zhi-Mei, Lai Shang-Lei, Zhu Jin-Yan, Ding Qin-Chao, Dou Xiao-Bing, Li Song-Tao

机构信息

School of Life Sciences, Zhejiang Chinese Medical University Hangzhou 310053, China.

School of Public Health, Zhejiang Chinese Medical University Hangzhou 310053, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2022 Feb;47(4):1017-1023. doi: 10.19540/j.cnki.cjcmm.20211008.701.

Abstract

This study explored the protective effect of atractylenolide Ⅰ(AO-Ⅰ) against acetaminophen(APAP)-induced acute liver injury(ALI) in mice and its underlying mechanism. C57 BL/6 J mice were randomly divided into a control group, an APAP group(500 mg·kg(-1)), a low-dose combination group(500 mg·kg(-1) APAP + 60 mg·kg(-1) AO-Ⅰ), and a high-dose combination group(500 mg·kg(-1) APAP + 120 mg·kg(-1) AO-Ⅰ). ALI was induced by intraperitoneal injection of APAP(500 mg·kg(-1)). AO-Ⅰ by intragastric administration was performed 2 hours before APAP treatment, and the control group received the same dose of solvent by intragastric administration or intraperitoneal injection. The protective effect of AO-Ⅰ against APAP-induced ALI was evaluated by detecting alanine aminotransferase(ALT) and aspartate aminotransferase(AST) levels in the plasma and H&E staining in liver tissues of mice. The malondialdehyde(MDA) and glutathione(GSH) content and catalase(CAT) activity in mouse liver tissues were detected to evaluate the effect of AO-Ⅰ on APAP-induced oxidative stress in the liver. The proteins in the liver p38 mitogen-activated protein kinase(p38 MAPK), c-jun N-terminal kinase(JNK), and nuclear factor kappa-B p65(NF-κB p65) signaling pathways were measured by Western blot, and the liver inflammatory cytokines interleukin-1β(IL-1β) and interleukin-6(IL-6) were detected by real-time PCR. Compared with the APAP group, the combination groups showed reduced APAP-induced ALT level and liver MDA content, potentiated liver CAT activity, and elevated GSH content. Mechanistically, AO-Ⅰ treatment significantly inhibited APAP-up-regulated MAPK phosphorylation and NF-κB p65, and significantly reduced the transcriptional activities of IL-1β and IL-6, downstream targets of NF-κB p65. AO-Ⅰ can improve APAP-induced ALI and the underlying mechanism is related to the inhibition of the MAPK/NF-κB p65 signaling pathway in APAP-challenged mice.

摘要

本研究探讨了白术内酯Ⅰ(AO-Ⅰ)对乙酰氨基酚(APAP)诱导的小鼠急性肝损伤(ALI)的保护作用及其潜在机制。将C57 BL/6 J小鼠随机分为对照组、APAP组(500 mg·kg⁻¹)、低剂量联合组(500 mg·kg⁻¹ APAP + 60 mg·kg⁻¹ AO-Ⅰ)和高剂量联合组(500 mg·kg⁻¹ APAP + 120 mg·kg⁻¹ AO-Ⅰ)。通过腹腔注射APAP(500 mg·kg⁻¹)诱导ALI。在APAP处理前2小时通过灌胃给予AO-Ⅰ,对照组通过灌胃或腹腔注射给予相同剂量的溶剂。通过检测小鼠血浆中的丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平以及肝组织的苏木精-伊红(H&E)染色来评估AO-Ⅰ对APAP诱导的ALI的保护作用。检测小鼠肝组织中的丙二醛(MDA)和谷胱甘肽(GSH)含量以及过氧化氢酶(CAT)活性,以评估AO-Ⅰ对APAP诱导的肝脏氧化应激的影响。通过蛋白质免疫印迹法检测肝脏p38丝裂原活化蛋白激酶(p38 MAPK)、c-jun氨基末端激酶(JNK)和核因子κB p65(NF-κB p65)信号通路中的蛋白质,通过实时聚合酶链反应检测肝脏炎性细胞因子白细胞介素-1β(IL-1β)和白细胞介素-6(IL-6)。与APAP组相比,联合组显示APAP诱导的ALT水平和肝脏MDA含量降低,肝脏CAT活性增强以及GSH含量升高。机制上,AO-Ⅰ处理显著抑制了APAP上调的MAPK磷酸化和NF-κB p65,并显著降低了NF-κB p65下游靶点IL-1β和IL-6的转录活性。AO-Ⅰ可以改善APAP诱导的ALI,其潜在机制与抑制APAP攻击小鼠中的MAPK/NF-κB p65信号通路有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验